Associated Papers
Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets.
Lobl MB et al.
Journal of Dermatological Science, 2020
Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2014
A novel PTEN gene promoter mutation and untypical Cowden syndrome.
Liu C et al.
Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu, 2013
Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
Teresi RE et al.
American Journal of Human Genetics, 2007
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP et al.
American Journal of Human Genetics, 2003
Select a paper to view details